Search the Newsreel

Tenon Medical Reports Second Quarter 2026 Financial Results

Tenon Medical (NASDAQ:TNON) announced its second quarter 2026 financial results, reporting a 127% increase in revenue to $1.3 million and a 232% increase in gross profit to $0.8 million compared to the prior year. The company also received FDA 510(k) clearance for its updated …

FDA Clears Tenon Medical System With Reusable Instruments

SBC Medical Group (NASDAQ:SBC) Posts Quarterly Earnings Results

Generate Biomedicines (GENB) Stock Price, News & Analysis

Generate Biomedicines (NASDAQ: GENB) utilizes machine learning and generative AI for novel therapeutic design and discovery. The company recently reported Q2 2026 earnings, missing analyst estimates, and has a "Moderate Buy" consensus rating with a price target of $25.40, suggesting a 62.4% upside. Its …

DiaMedica Therapeutics Inc. (DMAC) stock price, news, quote and history

This article provides a comprehensive overview of DiaMedica Therapeutics Inc. (DMAC), including its current stock price, financial statistics, historical data, and analyst insights. It highlights DMAC as a clinical-stage biopharmaceutical company focused on ischemic diseases, with its lead candidate DM199 in Phase 2/3 trials. …

Janus Henderson holds 11.1% of ICU Medical (ICUI) common stock via clients

Janus Henderson Group Ltd. has reported a beneficial ownership of 2,781,621 shares of ICU Medical, Inc. common stock, which constitutes 11.1% of the class. These shares are held through various Managed Portfolios where Janus Henderson's affiliated Asset Managers exercise investment and voting discretion, though …

Revolution Medicines (RVMD): Janus Henderson discloses 5.1% beneficial stake

Janus Henderson Group Ltd. has disclosed a 5.1% beneficial ownership stake in Revolution Medicines, Inc. (RVMD), holding 10,736,145 shares of common stock. These shares are managed across various client portfolios, with Janus Henderson exercising shared voting and dispositive power but disclaiming economic ownership, which …

Trading Systems Reacting to (UTMD) Volatility

This article analyzes the volatility of Utah Medical Products Inc. (NASDAQ: UTMD), highlighting a strong overweight bias across all sentiment horizons. It details three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, providing entry and exit points, targets, …

Praxis (PRAX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Marcio De'SouzaChief Financial Officer - Tim KellyPresident of Research and Development - Steve PetrouChief Operating Officer - Megan Sniecinski TAKEAWAYS Cash and …

Top Medical Properties Trust (MPT) Competitors 2026

All You Need to Know About DiaMedica Therapeutics (DMAC) Rating Upgrade to Buy

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including obstetrics, maternal-fetal medicine and neonatology, complemented by multiple pediatric subspecialties. The company has gained 23.9% in the year-to-date period, outperforming the industry's 1.2% …

Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update

Fresenius Medical Care stock is trading near $24, with a slight decline of 0.67% on the NYSE and 0.28% in Europe, as investors analyze the company's latest capital market update. This update details recent share repurchases and trading activity, suggesting a strategy to optimize …

Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript

Merit Medical Systems, Inc. (MMSI) Stock Forecasts

Argus has raised its target price for Merit Medical Systems Inc. (MMSI) to $100.00, citing the company's role as a medical equipment developer and manufacturer. The report, published on August 12, 2026, highlights MMSI's products for interventional cardiology, radiology, and endoscopy procedures. Full access …

Rockwell Medical Q2 2026 slides: margin gains fuel profitability push

Rockwell Medical (NASDAQ:RMTI) released its Q2 2026 results, showing 11% revenue growth and an 18% gross margin, despite narrowly missing Wall Street expectations. The company is advancing towards sustained profitability through operational improvements, customer diversification, and a strategic plan to exceed $100 million in …

Earnings call transcript: SBC Medical posts Q2 2026 revenue beat, EPS miss

SBC Medical Group Holdings reported mixed Q2 2026 results, exceeding revenue expectations with $49 million, a 13% year-on-year increase, but missing EPS forecasts at $0.10. The company highlighted a re-acceleration of growth following 2025 structural reforms, driven by clinic expansion, AI tool integration, and …

Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall

NeuroOne Medical Technologies reported a 16% year-over-year increase in Q3 2026 product revenue, reaching $2.0 million, driven by stronger sales of its OneRF brain ablation products and a 43% jump in orders. Despite revenue growth and improved gross margins, the company's net loss widened …

Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial

B. Riley Financial has reaffirmed its "Buy" rating for Journey Medical (NASDAQ:DERM), increasing its price target from $12 to $15, which suggests a 133.28% potential upside. Despite mixed analyst opinions, the company recently surpassed quarterly expectations, reporting an adjusted loss of $0.01 per share …

Earnings call transcript: Rockwell Medical Q2 2026 revenue rises 11%

Rockwell Medical, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Operational Efficiency Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Rockwell Medical (Nasdaq: RMTI) grows Q2 2026 sales, tightens loss and reaffirms 2026 outlook

Rockwell Medical (RMTI) announced strong Q2 2026 results, with net sales increasing 11% year-over-year to $17.8 million and gross profit rising 30%. The company significantly narrowed its net loss to $1.2 million and generated positive operating cash flow of $2.1 million, strengthening its cash …

ICU Medical Inc (ICUI) Chief Information Officer Ben Sousa Sells 2,250 Shares

ICU Medical Inc's Chief Information Officer, Ben Sousa, sold 2,250 shares of the company's stock for approximately $401,220. This transaction contributes to a trend of insider selling at the company, with 9 sells versus 2 buys over the last year. The stock is currently …

Inspire Medical Systems (INSP): Soleus Capital group reports 6.7% ownership stake

Soleus Capital Master Fund, L.P. and affiliated entities have reported a 6.7% ownership stake in Inspire Medical Systems, Inc. (INSP), holding 1,931,436 shares of common stock. This beneficial ownership is based on 28,910,375 shares outstanding as of July 30, 2026, and grants shared voting …

SBC Medical Group Holdings Incorporated 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SBC) 2026-08-13

SBC Medical Group Holdings Inc (NASDAQ:SBC) is expected to release its Q2 2026 earnings on August 13, 2026, with revenue projected at $45.45 million and earnings at $0.12 per share. For the full year 2026, revenue is estimated to be $180.98 million and earnings …

Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow

OrbusNeich Declares Interim Dividend of HK$0.08 Per Share

OrbusNeich Delivers Double-Digit Revenue Growth and Higher Margins in First-Half 2026

IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation

IceCure Medical announced two new peer-reviewed publications that support the increasing role of cryoablation in breast cancer treatment de-escalation. One review highlights ProSense®'s FDA authorization, ASBrS guidelines, and positive ICE3 trial outcomes, while the second expands cryoablation's use to axillary lymph node metastases for …

NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk

NeuroOne Medical Technologies (NMTC) reported a deeper net loss of $2.01 million for Q3 2026 and $5.83 million for the nine months ended June 30, 2026, significantly larger than the previous year. The company's cash and cash equivalents dwindled to $2.05 million, leading management …

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com

This article announces that Neuroone Medical Technologies Corp filed a Form 8K on August 13. It includes the company's stock symbol (NMTC) and its current performance. The content primarily serves as a placeholder for the filing and does not provide further details about the …

NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9%

NeuroOne (NMTC) reported a 16% increase in Q3 FY2026 product revenue to $1.97 million, with product gross margin expanding to 59.9%. Despite a net loss of $2.01 million, the company secured $2.7 million in new product orders and achieved ISO 13485:2016 certification. Significant progress …

NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026

CalciMedica shares see H.C. Wainwright neutral rating reiterated

H.C. Wainwright has reiterated a Neutral rating on CalciMedica (NASDAQ:CALC) following the company's second-quarter financial results. The company reported a wider-than-expected loss of $0.45 per share for Q2 2026 and ended the quarter with $18.6 million in cash, which is expected to fund operations …

Why is Journey Medical stock rallying today?

Journey Medical Corp (DERM) stock surged 10.9% in pre-open trading after reporting second-quarter 2026 results that significantly surpassed analyst expectations for both earnings and revenue. The company posted adjusted EPS of $0.10 against an estimated loss of $0.02, with revenue hitting $18.5 million, exceeding …

Form 8K SBC Medical Group Holdings Inc For: 13 August By Investing.com

This article reports that SBC Medical Group Holdings Inc. filed a Form 8K on August 13th. The brief mention indicates a significant event or disclosure made by the company, as Form 8K filings are used to announce unscheduled material events shareholders should know about.

DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week